Literature DB >> 12594107

HLA class II is associated with distal interphalangeal osteoarthritis.

N Riyazi1, J Spee, T W J Huizinga, G M T Schreuder, R R P de Vries, F W Dekker, M Kloppenburg.   

Abstract

OBJECTIVE: To investigate whether there is an association between HLA class II and distal interphalangeal osteoarthritis (DIP OA).
METHODS: The study group consisted of consecutive patients with and without DIP OA aged between 40 and 70 years. DIP OA was diagnosed by radiology. These patients were referred to an "Early Arthritis Clinic" (EAC) with different types of arthritis at an early stage. Patients with rheumatoid arthritis, systemic lupus erythematosus, spondyloarthropathies, and psoriatic arthritis were excluded for the purpose of this study. DNA typing for HLA-DR and x ray examination of the hands were performed at enrollment in the EAC. To establish whether the study group was representative of the Dutch population, a population based study in Zoetermeer (n=3243) for the prevalence of DIP OA and blood donors in the Leiden area (n=2400) for the HLA-DR antigen frequencies were used as references.
RESULTS: Fifty five patients (33%) of the total study group (n=166) had DIP OA. The prevalence of DIP OA and frequency of the HLA-DR alleles were similar to those of the two reference groups. Within the study group an association between DIP OA and HLA-DR2 and DR4 with respectively odds ratios of 2.4 (95% confidence interval (CI) 1.1 to 5.0) and 0.3 (95% CI 0.1 to 0.7) was found. No association was found between other HLA-DR alleles and DIP OA.
CONCLUSION: The study group is a representative sample of the Dutch population. The HLA-DR2 allele was more common in patients with DIP OA. Furthermore, an inverse relation was observed between DIP OA and HLA-DR4. The results confirm findings from other investigations implicating HLA-DR2 as a risk factor in the development of DIP OA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12594107      PMCID: PMC1754466          DOI: 10.1136/ard.62.3.227

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  12 in total

1.  [HLA antigens and Heberden nodes].

Authors:  A Brodsky; T Appelboom; A Govaerts; J P Famaey
Journal:  Acta Rhumatol       Date:  1979 Apr-Jun

2.  GENETIC FACTORS IN GENERALIZED OSTEO-ARTHROSIS.

Authors:  J H KELLGREN; J S LAWRENCE; F BIER
Journal:  Ann Rheum Dis       Date:  1963-07       Impact factor: 19.103

3.  Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions.

Authors:  K Vos; P Steenbakkers; A M Miltenburg; E Bos; M W van Den Heuvel; R A van Hogezand; R R de Vries; F C Breedveld; A M Boots
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

4.  HLA and Heberden's nodes in Mexican Mestizos.

Authors:  G Benavides; A Cervantes; B Silva; G Katona; J Lardizabal
Journal:  Clin Rheumatol       Date:  1985-03       Impact factor: 2.980

5.  Genetic influences on osteoarthritis in women: a twin study.

Authors:  T D Spector; F Cicuttini; J Baker; J Loughlin; D Hart
Journal:  BMJ       Date:  1996-04-13

6.  Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant.

Authors:  W Verduyn; I I Doxiadis; J Anholts; J J Drabbels; A Naipal; J D'Amaro; G G Persijn; M J Giphart; G M Schreuder
Journal:  Hum Immunol       Date:  1993-05       Impact factor: 2.850

7.  T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.

Authors:  H Takayanagi; K Ogasawara; S Hida; T Chiba; S Murata; K Sato; A Takaoka; T Yokochi; H Oda; K Tanaka; K Nakamura; T Taniguchi
Journal:  Nature       Date:  2000-11-30       Impact factor: 49.962

8.  Osteoarthritis and obesity in the general population. A relationship calling for an explanation.

Authors:  J L van Saase; J P Vandenbroucke; L K van Romunde; H A Valkenburg
Journal:  J Rheumatol       Date:  1988-07       Impact factor: 4.666

9.  T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis.

Authors:  L I Sakkas; C Scanzello; N Johanson; J Burkholder; A Mitra; P Salgame; C D Katsetos; C D Platsoucas
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

10.  Defining osteoarthritis of the hand for epidemiological studies: the Chingford Study.

Authors:  D Hart; T Spector; P Egger; D Coggon; C Cooper
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

View more
  4 in total

Review 1.  Joint and bone assessment in hand osteoarthritis.

Authors:  Roberta Ramonda; Paola Frallonardo; Estella Musacchio; Stefania Vio; Leonardo Punzi
Journal:  Clin Rheumatol       Date:  2013-10-08       Impact factor: 2.980

Review 2.  Genetics of osteoarthritis.

Authors:  Joanne M Jordan; Virginia B Kraus; Marc C Hochberg
Journal:  Curr Rheumatol Rep       Date:  2004-02       Impact factor: 4.592

3.  Immune Mediators in Osteoarthritis: Infrapatellar Fat Pad-Infiltrating CD8+ T Cells Are Increased in Osteoarthritic Patients with Higher Clinical Radiographic Grading.

Authors:  Jirun Apinun; Panjana Sengprasert; Pongsak Yuktanandana; Srihatach Ngarmukos; Aree Tanavalee; Rangsima Reantragoon
Journal:  Int J Rheumatol       Date:  2016-12-14

Review 4.  Review of Prospects of Biological Fluid Biomarkers in Osteoarthritis.

Authors:  Lich Thi Nguyen; Ashish Ranjan Sharma; Chiranjib Chakraborty; Balaji Saibaba; Moo-Eob Ahn; Sang-Soo Lee
Journal:  Int J Mol Sci       Date:  2017-03-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.